Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
5) Lynparza (Olaparib) Lynparza is a PARP inhibitor , meaning it inhibits poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. The drug is indicated for the treatment of metastatic HER2- breast cancer with inherited BRCA1 or 2 mutations, ovarian cancer and fallopian tube cancer, among others. billion, a 6.00
Let's personalize your content